← Back to headlines
Pulmonx Reaffirms 2026 Revenue Guidance, Anticipates H2 Growth
Pulmonx has reiterated its revenue guidance of $90 million to $92 million for 2026, citing ongoing cost-cutting measures and projecting a return to growth in the second half of 2026.
30 Apr, 05:22 — 30 Apr, 05:22
Sources
Showing 1 of 1 sources
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
When to Consult a Sleep Specialist for Insomnia and Daytime Sleepiness
just now
Latvian Parliament Unanimously Backs Full Diabetes Patient Compensation
2m ago